Unknown

Dataset Information

Metformin treatment in young children with fragile X syndrome.


ABSTRACT:

Background

Metformin is a drug commonly used in individuals with type 2 diabetes, obesity, and impaired glucose tolerance. It has a strong safety profile in both children and adults. Studies utilizing the Drosophila model and knock out mouse model of fragile X syndrome (FXS) have found metformin to rescue memory, social novelty deficits, and neuroanatomical abnormalities. These studies provided preliminary evidence that metformin could be used as a targeted treatment for the cognitive and behavioral problems associated with FXS. Previously, a case series of children and adults with FXS treated with metformin demonstrated improvements in irritability, social responsiveness, language, and hyperactivity.

Methods

Here, we present nine children with FXS between 2 and 7 years of a

SUBMITTER: Biag HMB 

PROVIDER: S-EPMC6825840 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature